Innogenetics NV is an international biotechnological company headquartered in Gent, Belgium that develops and markets diagnostic products to improve therapy management and patient health. Innogenetics' diagnostics business unit develops and markets a wide range of diagnostic assays with a focus on molecular diagnostics and multiparameter testing. Its products are sold in over 90 countries through its six subsidiaries and a large number of distributors. In 2007, diagnostics product sales totaled EUR 47 million, more than 95% of which were achieved outside Belgium. Founded in 1985, Innogenetics is listed on Euronext Brussels [EBR: INNX]. On April 25, Innogenetics and Solvay announced the launch of an offer by Solvay to acquire all the outstanding shares, warrants and convertible bonds of Innogenetics.
| Website | http://www.innogenetics.com |
| Revenue | $34 million |
| Employees | View employees |
| Founded | 1985 |
| Address | 1111 Alderman Dr. Ste. 200, Alpharetta, Georgia 30005, US |
| Phone | (678) 393-1672 |
| Fax | (678) 393-1673 |
| Industry | Biotechnology, Medical Testing & Clinical Laboratories, Healthcare, Science and Engineering, Drug Discovery, Genetics, Health Care, Health Diagnostics |
| Competitors | Roche, Thermo Fisher Scientific, BD, Illumina, bioMérieux, Abbott, Merck Group, QIAGEN, Exact Sciences, Genomic Health +44 more (view full list) |
| SIC | SIC Code 807 Companies, SIC Code 80 Companies, SIC Code 8071 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 621 Companies |
Looking for a particular Innogenetics NV employee's phone or email?
Innogenetics NV Questions
The Innogenetics NV annual revenue was $34 million in 2026.
Innogenetics NV is based in Alpharetta, Georgia.
The NAICS codes for Innogenetics NV are [62, 621].
The SIC codes for Innogenetics NV are [807, 80, 8071].
